What is Foster?
Founded in 1989 and headquartered in Putnam, Connecticut, Foster has established itself as a premier provider of formulation development and production services for polymer enhancements. The company specializes in the creation of radiopaque fillers, high-performance colors, and bespoke specialty additives tailored specifically for the medical device industry. By bridging the gap between raw material science and clinical application, Foster enables manufacturers to achieve superior device functionality, visibility, and biocompatibility.
The firm's market position is defined by its deep technical expertise and a long-standing commitment to quality assurance. In an industry where material failure is not an option, Foster acts as a vital link in the supply chain, ensuring that medical device OEMs have access to the advanced chemical formulations required for next-generation surgical and diagnostic tools.
How much funding has Foster raised?
Foster has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Foster
PPP
Public-Private Partnership
What's next for Foster?
With this major enterprise-level funding, Foster is well-positioned to accelerate its strategic roadmap, focusing on the expansion of its R&D facilities and the optimization of its manufacturing throughput. The company is expected to leverage this investment to deepen its integration within the medical device ecosystem, potentially exploring new material frontiers such as advanced bio-resorbable polymers and enhanced antimicrobial additives.
Looking ahead, the firm will likely prioritize operational efficiency and the scaling of its proprietary formulation processes to meet the increasing global demand for high-precision medical components. By maintaining its focus on innovation and technical excellence, Foster is poised to sustain its growth trajectory, ensuring that it remains at the forefront of material science advancements for the foreseeable future.
